AGP Picks
View all

French Guiana Wellness Network
Provided by AGP

French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on August 6, 2026

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
Aug. 6, 2026

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week

Indeterminate GlobeNewswire
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
Aug. 6, 2026

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Indeterminate GlobeNewswire
Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Aug. 6, 2026

Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement
Aug. 6, 2026

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Indeterminate GlobeNewswire
Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results
Aug. 6, 2026

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Ascendis Announces COACH Week 78 Results and Provides Update on Achondroplasia Programs and YUVIWEL® Uptake in the U.S.
Aug. 6, 2026

Ascendis Announces COACH Week 78 Results and Provides Update on Achondroplasia Programs and YUVIWEL® Uptake in the U.S.

Indeterminate GlobeNewswire
Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study
Aug. 6, 2026

Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study

Indeterminate GlobeNewswire
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
Aug. 6, 2026

argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

Indeterminate GlobeNewswire
SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
Aug. 6, 2026

SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
Aug. 6, 2026

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Indeterminate GlobeNewswire
Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
Aug. 6, 2026

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Indeterminate GlobeNewswire
Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update
Aug. 6, 2026

Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
Aug. 6, 2026

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

Indeterminate GlobeNewswire
Cronos Group Reports 2026 Second Quarter Results
Aug. 6, 2026

Cronos Group Reports 2026 Second Quarter Results

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates 
Aug. 6, 2026

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates 

Indeterminate GlobeNewswire
Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform
Aug. 6, 2026

Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform

Indeterminate GlobeNewswire
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
Aug. 6, 2026

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Indeterminate GlobeNewswire
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
Aug. 6, 2026

Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference

Indeterminate GlobeNewswire
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
Aug. 6, 2026

Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth

Indeterminate GlobeNewswire
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
Aug. 6, 2026

Ocugen Provides Business Update with Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

French Guiana Wellness Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.